Week 15 '25-26 Mon 1/26-Sun 2/1 | |||||||||
| Team | Coach Rating | M | T | W | T | F | S | S | Total |
|---|---|---|---|---|---|---|---|---|---|
| (8-5) | 337 | 242 | 399 | 197 | 405 | 190 | 280 | 2,051.9 | |
| (8-5) | 326 | 123 | 333 | 247 | 216 | 161 | 283 | 1,688.9 | |
| Final Non-Division Game | |||||||||
| Name | Opp | Stats | Day | Total | Pos | Total | Day | Stats | Opp | Name | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PG | 144.7 | 32.7 | 18 Pts 4 Reb 4 Ast | G BOS | ||||||||
SG/SF CHA | 30 Pts 8 Reb 2 Ast | 71.6 | 214.95 | SG | 170.2 | 68.1 | 23 Pts 8 Reb 7 Ast | G ATL | ||||
G/SF PHI | 9 Pts 6 Reb 1 Ast | 20.3 | 132.05 | G | 54.15 | 21.55 | 12 Pts 2 Reb 1 Ast | G LAL | ||||
SG/F IND | 18 Pts 2 Reb 4 Ast | 34.7 | 112.95 | SF | 99.3 | 22.8 | 10 Pts 4 Reb 1 Ast | SG/SF GSW | ||||
F ORL | 37 Pts 10 Reb 4 Ast | 64.95 | 219.9 | FLEX | 155.7 | 54.4 | 15 Pts 4 Reb 8 Ast | G/SF MIN | ||||
PF/C ATL | 12 Pts 10 Reb 2 Ast | 36.1 | 77.5 | PF | 175.4 | 41.8 | 15 Pts 7 Reb 6 Ast | F ATL | ||||
C BOS | 4 Pts 4 Reb 6 Ast | 19.8 | 93.6 | C | ||||||||
C CHI | 18 Pts 11 Reb 5 Ast | 48.75 | 159.65 | PF/C | 143.8 | 47.85 | 15 Pts 17 Reb 2 Ast | C MIN | ||||
C POR | 9 Pts 15 Reb 1 Ast | 41.3 | 150.95 | ANY | 65.85 | 35.9 | 14 Pts 3 Reb 3 Ast | G POR | ||||
| ANY | 99.9 | 0.8 | 1 Reb 1 Ast | SG/SF CHI | ||||||||
| Total | 337.5 | 2,051.9 | 1,688.9 | 325.9 | Total | |||||||
| Optimum | 337.5 | 1,535.75 | 1,448.35 | 325.1 | Optimum | |||||||
Benched | ||||||||||||
PG NYK | — | 171.95 | BN | 31.05 | — | SG MIL | ||||||
G WAS | — | 119.45 | BN | 70.25 | — | G LAC | ||||||
DTDS. Castle G/SF SAS | — | 80.75 | BN | 36.3 | — | G SAC | ||||||
F PHX | — | 107.55 | BN | 138.75 | — | F DET | ||||||
SG/F TOR | — | 145.85 | BN | 64.05 | — | OUTJ. Nurki膰 C UTA | ||||||
SG/F UTA | — | 108.05 | BN | 154.8 | — | C SAS | ||||||
PF/C NOP | — | 99 | BN | |||||||||
| Total | 0 | 0 | 0 | 0 | Total | |||||||
Injured Reserve | ||||||||||||
OUTJ. Tatum F BOS | — | — | IR | 154.1 | — | F DEN | ||||||
| IR | 111 | — | OUTP. George SG/F PHI | |||||||||